Post Date December, 03 2023
Benign prostatic hyperplasia (BPH) is one of the most common diseases in urology. The patients are mainly middle-aged and elderly men. Common symptoms include: fine flow of urine, discontinuities; Feeling of endless urination; Holding or delaying urination when starting urination; Frequent urination, especially frequent nocturnal urination; Urgent urination cannot be tolerated; Urinary incontinence, pain in urination, etc.
Although the Chinese government has designated October 28th as the "Men's Health Day" every year, there are still certain misunderstandings between the media and the public regarding "men's health.". In fact, it is not only "ED" (erectile dysfunction) that affects male health, but also benign prostatic hyperplasia (BPH) is a "hidden killer" that threatens male health. It is worrisome that there is a significant lack of awareness among Chinese men about benign prostatic hyperplasia, especially in northern regions. Many male patients only seek medical attention after experiencing serious complications, thereby missing the best opportunity to control and treat the disease.
Generally speaking, the treatment of benign prostatic hyperplasia is mainly carried out using drug therapy. First of all, doctors understand the symptoms during the observation period, determine the condition, and then prescribe medication to the case. Currently, domestic drugs for treating this disease can be divided into three categories: The first category is α Blockers are used to alleviate symptoms. Their mechanism of action is to dilate smooth muscle, relax bladder outlet, and play a role in urination and emergency rescue. However, because it "cures the symptoms but not the root cause" - it cannot reduce the size of the prostate, so it is used as an adjuvant treatment. The second class of drugs is 5 α Reductase inhibitors, which can effectively reduce the enlarged prostate volume, increase urinary flow rate, and reduce the occurrence of acute urinary retention, thereby completely eliminating the root cause, have become the main choice of clinical medication for doctors. The representative class of drugs is Baoliezhi. The third category of drugs is animal and plant drugs. However, in terms of efficacy, the mechanism of action of these drugs is still unclear and needs to be determined through larger and more comprehensive studies. Therefore, there is no sufficient basis for direct clinical use.
It is worth noting that the duration of a medication course is generally relatively long, so it is important to persevere in taking the medication until the symptoms completely disappear. "Because the treatment of benign prostatic hyperplasia is somewhat similar to the weight loss process, if treatment is not adhered to, the already shrunken prostate may rebound.".
Surgical treatment is also an important means of treating benign prostatic hyperplasia. However, as patients generally have to endure much greater pain and risk than drug treatment, it is recommended to choose carefully - only use it when medical treatment is too late and the complications caused are no longer curable by drug treatment.
